Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now.
作者信息
Luker Gary D, Boettcher Adeline N
机构信息
Department of Radiology, University of Michigan, Ann Arbor, Michigan.
出版信息
Radiol Imaging Cancer. 2021 Jan 22;3(1):e210003. doi: 10.1148/rycan.2021210003. eCollection 2021 Jan.
Abstract
摘要
相似文献
1
Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now.2019年冠状病毒病对癌症影像学临床护理与研究的影响：我们目前的状况
Radiol Imaging Cancer. 2021 Jan 22;3(1):e210003. doi: 10.1148/rycan.2021210003. eCollection 2021 Jan.
2
Editorial: immunosuppression and SARS-CoV-2 vaccination-where do we stand?社论：免疫抑制与 SARS-CoV-2 疫苗接种——我们处于什么位置？
Aliment Pharmacol Ther. 2023 Jan;57(1):163-164. doi: 10.1111/apt.17276.
3
The dangers of immunosuppression and solid organ transplant in the SARS-CoV-2 pandemic era.新冠疫情时代免疫抑制与实体器官移植的风险
Pol Arch Intern Med. 2022 Feb 28;132(2). doi: 10.20452/pamw.16212.
4
Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients.癌症还是 COVID-19？癌症患者 COVID-19 疫苗接种建议的综述。
Curr Treat Options Oncol. 2021 Sep 13;22(10):95. doi: 10.1007/s11864-021-00903-7.
5
Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression.慢性肾脏病或免疫抑制儿童中SARS-CoV-2-IgG抗体的流行情况
Clin J Am Soc Nephrol. 2021 Jul;16(7):1097-1099. doi: 10.2215/CJN.00330121. Epub 2021 Jun 7.
6
COVID-19 in an adolescent with aplastic anemia undergoing immunosuppressive therapy: A case report and details of antibody testing for SARS-CoV-2.一名正在接受免疫抑制治疗的再生障碍性贫血青少年的COVID-19感染：病例报告及SARS-CoV-2抗体检测详情
Pediatr Blood Cancer. 2022 Feb;69(2):e29332. doi: 10.1002/pbc.29332. Epub 2021 Sep 5.
7
Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.雷帕霉素和菊粉增强疫苗反应刺激（RIVASTIM）-雷帕霉素：一项随机对照试验的研究方案，旨在用雷帕霉素调节免疫抑制，改善肾移植受者对 SARS-CoV-2 疫苗的反应。
Trials. 2022 Sep 15;23(1):780. doi: 10.1186/s13063-022-06634-w.
8
Transplant Immunosuppression Management and COVID-19.移植免疫抑制管理与新型冠状病毒肺炎
Exp Clin Transplant. 2022 Jul;20(7):706-707. doi: 10.6002/ect.2020.0179. Epub 2020 Sep 17.
9
Survey on the impact of COVID19 in patients on immunosuppression for ocular and orbital inflammatory disorders.关于新型冠状病毒肺炎对眼部和眼眶炎性疾病免疫抑制患者影响的调查。
Eur J Ophthalmol. 2022 Jan;32(1):NP280-NP282. doi: 10.1177/11206721211008039. Epub 2021 Apr 8.
10
[Repeatedly re-detectable positive for SARS-CoV-2 by RT-PCR in the immunosuppressive therapy of a patient: a case report and literature review].[一名患者免疫抑制治疗期间SARS-CoV-2经逆转录聚合酶链反应多次检测呈阳性：病例报告及文献综述]
Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):520-522. doi: 10.3760/cma.j.issn.0253-2727.2023.06.016.
引用本文的文献
1
Trends in oncological imaging during the COVID-19 pandemic through the vaccination era.COVID-19 大流行及疫苗接种时代的肿瘤影像学趋势。
Cancer Med. 2023 Apr;12(8):9902-9911. doi: 10.1002/cam4.5678. Epub 2023 Feb 12.
2
Institutional Strategies to Maintain and Grow Imaging Research During the COVID-19 Pandemic.机构策略以维持和促进 COVID-19 大流行期间的影像研究。
Acad Radiol. 2023 Apr;30(4):631-639. doi: 10.1016/j.acra.2022.12.045. Epub 2023 Jan 6.
3
Validation of a highly accelerated post-contrast wave-controlled aliasing in parallel imaging (CAIPI) 3D-T1 MPRAGE compared to standard 3D-T1 MPRAGE for detection of intracranial enhancing lesions on 3-T MRI.对比标准 3D-T1 MPRAGE，验证高加速后对比控制随机重叠并行成像（CAIPI）3D-T1 MPRAGE 在 3T MRI 上检测颅内增强病变的能力。
Eur Radiol. 2023 Apr;33(4):2905-2915. doi: 10.1007/s00330-022-09265-6. Epub 2022 Dec 2.
4
Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists.COVID-19大流行对葡萄牙乳腺癌管理的影响：一项基于横断面调查的肿瘤内科医生研究
Oncol Ther. 2022 Jun;10(1):225-240. doi: 10.1007/s40487-022-00191-7. Epub 2022 Mar 21.
5
Haematological malignancies implications during the times of the COVID-19 pandemic.COVID-19大流行期间血液系统恶性肿瘤的影响
Oncol Lett. 2021 Dec;22(6):856. doi: 10.3892/ol.2021.13117. Epub 2021 Oct 29.
6
Imaging in the COVID-19 era: Lessons learned during a pandemic.新冠疫情时代的影像学：大流行期间的经验教训。
World J Radiol. 2021 Jun 28;13(6):192-222. doi: 10.4329/wjr.v13.i6.192.
7
Get comfortable with being uncomfortable: Experiences from diagnostic radiographers a year into the COVID-19 pandemic.习惯身处不适之中：新冠疫情爆发一年来诊断放射技师的经历
J Med Imaging Radiat Sci. 2021 Sep;52(3):332-339. doi: 10.1016/j.jmir.2021.05.003. Epub 2021 May 14.
本文引用的文献
1
Transitioning to a New Normal after COVID-19: Preparing to Get Back on Track for Cancer Imaging.新冠疫情后迈向新常态：为癌症影像检查重回正轨做准备。
Radiol Imaging Cancer. 2020 Apr 15;2(3):e204011. doi: 10.1148/rycan.2020204011. eCollection 2020 May.
2
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
3
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.SARS-CoV-2 mRNA-1273疫苗接种后反应的持久性。
N Engl J Med. 2021 Jan 7;384(1):80-82. doi: 10.1056/NEJMc2032195. Epub 2020 Dec 3.
4
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.癌症免疫抑制治疗后活的严重急性呼吸综合征冠状病毒2的脱落
N Engl J Med. 2020 Dec 24;383(26):2586-2588. doi: 10.1056/NEJMc2031670. Epub 2020 Dec 1.
5
COVID-19 and cancer.新型冠状病毒肺炎与癌症。
Science. 2020 Jun 19;368(6497):1290. doi: 10.1126/science.abd3377.
6
Impact of the COVID-19 crisis on imaging in oncological trials.2019年冠状病毒病危机对肿瘤学试验影像学的影响。
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2054-2058. doi: 10.1007/s00259-020-04910-y.
Zotero 插件